Clinical Trial Update: Cannabidiol for Reducing Drinking in Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol to reduce drinking in people with alcohol use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Hôpital le Vinatier | Conditions: Alcohol Use Disorder | Phase 2 | Status: RECRUITING